Empty IV Bags Market Size & Growth Forecast 2026–2035, By Segments (Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Empty IV Bags Market size stood at USD 5.67 Billion in 2025 and is predicted to grow at a 8.8% CAGR from 2026 to 2035, surpassing USD 13.18 Billion by 2035. The industry revenue for 2026 is assessed at USD 6.11 billion.
Get more details on this report
Request Free Sample ReportEmpty IV Bags Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to established hospital infrastructure, high procedural volumes, and consistent demand for sterile infusion systems supported by mature procurement networks and clinical reliability requirements.
- Asia Pacific is projected at 9.94% CAGR driven by expanding healthcare capacity, rising treatment volumes, and growing adoption of intravenous therapies supported by improving manufacturing and distribution reach.
Segment Momentum
- Non-PVC holds a 52.92% share due to rising preference for safer and more compatible materials in IV fluid storage and delivery, supporting better performance across sterilization and drug-contact conditions.
- Non-PVC is also the fastest-growing segment as healthcare providers increasingly prioritize material safety, compatibility, and handling performance, reinforcing its expanding adoption across IV packaging applications.
Market Expansion Drivers
- Rising cancer prevalence accelerating adoption of non-PVC chemotherapy-compatible IV bags.
- Growing home healthcare and parenteral nutrition demand increasing sterile IV bag utilization.
- Expanding sustainability initiatives driving healthcare transition toward recyclable polyolefin IV packaging.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Top players in the empty IV bags market include Baxter International Inc. (United States), B. Braun SE (Germany), ICU Medical, Inc. (United States), Fresenius Kabi AG (Germany), Becton, Dickinson and Company (United States), RENOLIT SE (Germany), Technoflex SA (France), Wipak Group (Finland), JW Life Science Corporation (South Korea), PolyCine GmbH (Germany).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As oncology treatment volumes rise, procurement increasingly shifts toward infusion containers that can safely handle hazardous and stability-sensitive drug formulations, which is increasing demand for the empty IV bags market. Many chemotherapy agents require compatibility with non-PVC materials to reduce risks such as drug interaction, sorption, or leachable exposure, prompting hospitals and cancer centers to replace conventional bag formats with higher-specification alternatives. This changes purchasing behavior from routine bulk sourcing to therapy-specific selection, supporting market development for manufacturers supplying compliant multilayer and polyolefin-based empty bags suited to oncology workflows.
Growing home healthcare and parenteral nutrition demand increasing sterile IV bag utilization
The expansion of home-based infusion care is increasing reliance on ready-to-fill, sterile, and lightweight administration formats, supporting market expansion in the empty IV bags market. Parenteral nutrition, hydration therapy, and other extended-use infusion regimens require packaging that is easy to transport, store, and handle outside acute care settings, which raises the importance of sterility assurance, seal integrity, and compatibility with decentralized filling and distribution models. As providers and contract packagers adapt supply chains for home healthcare delivery, utilization of empty IV bags rises in practical tandem with the shift away from exclusively hospital-administered infusion care.
Expanding sustainability initiatives driving healthcare transition toward recyclable polyolefin IV packaging
Environmental procurement criteria are beginning to influence material selection in medical packaging, contributing to market size growth in the empty IV bags market as healthcare systems reassess legacy PVC-based formats. Recyclable polyolefin IV packaging is gaining traction because it aligns more closely with hospital waste-reduction programs and manufacturer sustainability commitments while also fitting existing demand for clinically acceptable non-glass, flexible infusion containers. The result is not simply a material substitution trend but a change in sourcing priorities, where suppliers able to offer recyclable and lower-impact empty IV bag solutions are better positioned in contract decisions and product standardization efforts.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising cancer prevalence accelerating adoption of non-PVC chemotherapy-compatible IV bags | 2.00% | High | North America, Europe | High | Near Term |
| Growing home healthcare and parenteral nutrition demand increasing sterile IV bag utilization | 1.70% | Moderate | Asia Pacific, North America | High | Mid Term |
| Expanding sustainability initiatives driving healthcare transition toward recyclable polyolefin IV packaging | 1.40% | High | Europe, Asia Pacific | Medium | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the largest regional share of the empty IV bags market in 2025, backed by its well-established hospital and infusion care infrastructure, consistent procedural volumes, and broad use of sterile fluid delivery systems across acute and outpatient settings. The region’s leadership is strengthened by mature procurement networks, stringent quality requirements, and routine demand from healthcare providers that rely on dependable supply of empty IV bags for medication preparation, hydration, and nutrition delivery in daily clinical practice.
Asia Pacific is projected to expand at a 9.94% CAGR over the forecast period, with growth in the empty IV bags market being fueled by the ongoing expansion of healthcare capacity, rising patient treatment volumes, and wider adoption of modern infusion practices across hospitals and care centers. Demand is accelerating as providers increase access to intravenous therapy, while manufacturing expansion and improving distribution reach make these products more available across both established urban systems and developing healthcare markets.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Pharmaceutical Packaging StandardsGermany emphasizes empty IV bags that support stringent pharmaceutical manufacturing standards and efficient aseptic filling operations. German producers invest in advanced packaging materials that enhance product integrity and manufacturing consistency.
France 🇫🇷
Hospital Supply AssuranceFrance maintains demand for empty IV bags through healthcare procurement and pharmaceutical packaging modernization. French suppliers prioritize dependable sterile packaging solutions that support uninterrupted medical treatment and regulatory compliance.
Italy 🇮🇹
Flexible Medical PackagingItaly supports the empty IV bags market through pharmaceutical manufacturing and hospital distribution networks. Italian manufacturers focus on flexible packaging materials that improve handling efficiency while maintaining product safety throughout the supply chain.
Japan 🇯🇵
Precision Medical PackagingJapan focuses on empty IV bags designed for high-quality infusion therapies and reliable pharmaceutical packaging. Japanese manufacturers prioritize advanced film technologies and production precision to support safe healthcare delivery.
South Korea 🇰🇷
Healthcare Supply ExpansionSouth Korea strengthens domestic production of empty IV bags to support pharmaceutical manufacturing and expanding healthcare infrastructure. Companies increasingly adopt automated manufacturing systems that improve quality assurance and production efficiency.
United States 🇺🇸
Sterile Packaging ReliabilityThe U.S. prioritizes high-quality empty IV bags to strengthen pharmaceutical manufacturing and hospital supply resilience. Manufacturers increasingly focus on sterile production, material compatibility, and regulatory compliance for injectable drug packaging applications.
Segment Leadership and Growth Trends
Empty IV Bags Market Share (%), Product, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportWithin the empty IV bags market, Non-PVC held a 52.92% share in 2025, making it the leading product segment while also sustaining the strongest growth momentum. Its position is being reinforced by growing preference for IV packaging materials that better align with evolving safety, compatibility, and handling requirements in fluid delivery applications. In the empty IV bags market, Non-PVC products continue to gain traction because healthcare providers and manufacturers are increasingly attentive to material performance across storage, sterilization, and drug-contact conditions, which gives this segment an advantage in both current adoption and continued expansion.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | PVC, Non-PVC | Non-PVC | Non-PVC |
Competitive Landscape and Market Positioning
1. Baxter International Inc. (United States)
2. B. Braun SE (Germany)
3. ICU Medical Inc. (United States)
4. Fresenius Kabi AG (Germany)
5. Becton Dickinson and Company (United States)
6. RENOLIT SE (Germany)
7. Technoflex SA (France)
8. Wipak Group (Finland)
9. JW Life Science Corporation (South Korea)
10. PolyCine GmbH (Germany)
Demand for reliable sterile packaging is driving innovation in the empty IV bags market. Manufacturing enhancements are improving safety and production scalability. Supply chain improvements are ensuring consistent availability across healthcare systems. The empty IV bags market is evolving through efficiency-driven healthcare packaging transformation.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Gufic Biosciences | Jun-22 | Gufic Biosciences launched dual-chamber IV bags made from polypropylene (DEHP-free) with peelable aluminum foil. The design enables storage of unstable drugs requiring reconstitution immediately prior to administration, supporting improved drug stability management and safer infusion preparation workflows in hospital and clinical settings. |
| Fresenius Kabi | May-22 | Fresenius Kabi acquired Ivenix, Inc., strengthening its position in the U.S. infusion therapy market. The acquisition enhances its integrated infusion systems portfolio and expands its ability to deliver connected drug delivery solutions across hospital-based intravenous therapy and fluid administration ecosystems. |
| B. Braun Medical Inc. | Jan-22 | B. Braun received FDA approval for its new manufacturing facility in Daytona Beach, Florida, dedicated to producing 500 mL and 1,000 mL Excel Plus IV bags with 0.9% sodium chloride. The facility expands DEHP-free, PVC-free, and latex-free sterile IV bag production capacity in the U.S. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Empty IV Bags Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Empty IV Bags Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow much revenue does the empty IV bags market generate?
What is the projected value of the empty IV bags industry by 2035?
How is the growth of home healthcare influencing demand in the empty IV bags market?
Why are sustainability initiatives reshaping procurement strategies in the empty IV bags market?
Why does Non-PVC lead the empty IV bags market?
How is Non-PVC contributing to growth in the empty IV bags market?
Why does North America lead the empty IV bags market?
What is driving Asia Pacific growth in empty IV bags market?
What are the prominent companies operating in the empty IV bags landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization